These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 10698186
1. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Nam TJ, Busby WH, Rees C, Clemmons DR. Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186 [Abstract] [Full Text] [Related]
2. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Parker A, Rees C, Clarke J, Busby WH, Clemmons DR. Mol Biol Cell; 1998 Sep; 9(9):2383-92. PubMed ID: 9725901 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. Nam TJ, Busby W, Clemmons DR. Endocrinology; 1997 Jul; 138(7):2972-8. PubMed ID: 9202242 [Abstract] [Full Text] [Related]
6. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5. Rees C, Clemmons DR. J Cell Biochem; 1998 Dec 01; 71(3):375-81. PubMed ID: 9831074 [Abstract] [Full Text] [Related]
7. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Arai T, Busby W, Clemmons DR. Endocrinology; 1996 Nov 01; 137(11):4571-5. PubMed ID: 8895319 [Abstract] [Full Text] [Related]
11. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Gockerman A, Prevette T, Jones JI, Clemmons DR. Endocrinology; 1995 Oct 01; 136(10):4168-73. PubMed ID: 7545099 [Abstract] [Full Text] [Related]
14. Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells. Moralez A, Busby WH, Clemmons D. Endocrinology; 2003 Jun 01; 144(6):2489-95. PubMed ID: 12746311 [Abstract] [Full Text] [Related]
15. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. Arai T, Parker A, Busby W, Clemmons DR. J Biol Chem; 1994 Aug 12; 269(32):20388-93. PubMed ID: 7519608 [Abstract] [Full Text] [Related]
16. Role of insulin-like growth factor binding proteins in the control of IGF actions. Clemmons DR, Busby WH, Arai T, Nam TJ, Clarke JB, Jones JI, Ankrapp DK. Prog Growth Factor Res; 1995 Aug 12; 6(2-4):357-66. PubMed ID: 8817679 [Abstract] [Full Text] [Related]
17. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I. Bramani S, Song H, Beattie J, Tonner E, Flint DJ, Allan GJ. J Mol Endocrinol; 1999 Aug 12; 23(1):117-23. PubMed ID: 10425523 [Abstract] [Full Text] [Related]
18. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis. Beattie J, Phillips K, Shand JH, Szymanowska M, Flint DJ, Allan GJ. J Mol Endocrinol; 2005 Feb 12; 34(1):163-75. PubMed ID: 15691886 [Abstract] [Full Text] [Related]